S 2720 · 117th Congress · Armed Forces and National Security
Veterans’ Prostate Cancer Treatment and Research Act
Bill Progress
✓
Introduced2
Committee3
Senate Vote4
House5
EnactedLatest: Committee on Veterans' Affairs. Ordered to be reported without amendment favorably.(2021-12-15)
Plain Language Summary
[AI summary unavailable — showing source text]
Veterans' Prostate Cancer Treatment and Research Act This bill requires the Department of Veterans Affairs (VA) to establish in its National Surgery Office an interdisciplinary clinical pathway for all stages of prostate cancer. Clinical pathways are health care management tools designed around research and evidence-based practices that provide direction for the care and treatment of a specific condition. The clinical pathway must include specified elements, such as a diagnosis pathway and a treatment pathway. The VA must consult with and incorporate feedback from (1) veterans who have received prostate cancer care at its medical facilities, and (2) experts in multidisciplinary cancer care and clinical research. Additionally, the VA must publish the clinical pathway on a public VA website and annually update the pathway as needed based on medical literature and evidence-based guidelines. The bill also requires the VA to submit a plan to establish a prostate cancer program using the comprehensive prostate cancer clinical pathway.…
Summarized by Claude AI · Non-partisan · For informational purposes only
CBO Cost Estimate
Congressional Budget OfficeS. 2720, Veterans’ Prostate Cancer Treatment and Research Act
Feb 4, 2022As ordered reported by the Senate Committee on Veterans’ Affairs on December 15, 2021
Full CBO report ↗Official non-partisan budget analysis by the Congressional Budget Office
Cosponsors (6)
4 Democrats2 Republicans